rs6811856

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_173660.5(DOK7):​c.1113A>C​(p.Ser371Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.214 in 1,579,746 control chromosomes in the GnomAD database, including 40,280 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3574 hom., cov: 34)
Exomes 𝑓: 0.22 ( 36706 hom. )

Consequence

DOK7
NM_173660.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -4.44

Publications

22 publications found
Variant links:
Genes affected
DOK7 (HGNC:26594): (docking protein 7) The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
DOK7 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 4-3493099-A-C is Benign according to our data. Variant chr4-3493099-A-C is described in ClinVar as Benign. ClinVar VariationId is 128904.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.44 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.497 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DOK7NM_173660.5 linkc.1113A>C p.Ser371Ser synonymous_variant Exon 7 of 7 ENST00000340083.6 NP_775931.3 Q18PE1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DOK7ENST00000340083.6 linkc.1113A>C p.Ser371Ser synonymous_variant Exon 7 of 7 1 NM_173660.5 ENSP00000344432.5 Q18PE1-1

Frequencies

GnomAD3 genomes
AF:
0.188
AC:
28587
AN:
152040
Hom.:
3579
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0557
Gnomad AMI
AF:
0.278
Gnomad AMR
AF:
0.152
Gnomad ASJ
AF:
0.211
Gnomad EAS
AF:
0.514
Gnomad SAS
AF:
0.225
Gnomad FIN
AF:
0.385
Gnomad MID
AF:
0.180
Gnomad NFE
AF:
0.216
Gnomad OTH
AF:
0.191
GnomAD2 exomes
AF:
0.224
AC:
42420
AN:
189222
AF XY:
0.227
show subpopulations
Gnomad AFR exome
AF:
0.0524
Gnomad AMR exome
AF:
0.145
Gnomad ASJ exome
AF:
0.219
Gnomad EAS exome
AF:
0.489
Gnomad FIN exome
AF:
0.380
Gnomad NFE exome
AF:
0.210
Gnomad OTH exome
AF:
0.216
GnomAD4 exome
AF:
0.217
AC:
309943
AN:
1427588
Hom.:
36706
Cov.:
110
AF XY:
0.217
AC XY:
154015
AN XY:
708228
show subpopulations
African (AFR)
AF:
0.0481
AC:
1584
AN:
32950
American (AMR)
AF:
0.143
AC:
5810
AN:
40532
Ashkenazi Jewish (ASJ)
AF:
0.222
AC:
5676
AN:
25624
East Asian (EAS)
AF:
0.507
AC:
19129
AN:
37738
South Asian (SAS)
AF:
0.209
AC:
17299
AN:
82722
European-Finnish (FIN)
AF:
0.381
AC:
16812
AN:
44122
Middle Eastern (MID)
AF:
0.148
AC:
850
AN:
5742
European-Non Finnish (NFE)
AF:
0.209
AC:
229974
AN:
1098934
Other (OTH)
AF:
0.216
AC:
12809
AN:
59224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
18630
37260
55890
74520
93150
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7984
15968
23952
31936
39920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.188
AC:
28585
AN:
152158
Hom.:
3574
Cov.:
34
AF XY:
0.195
AC XY:
14505
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.0556
AC:
2310
AN:
41546
American (AMR)
AF:
0.152
AC:
2330
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.211
AC:
731
AN:
3470
East Asian (EAS)
AF:
0.514
AC:
2649
AN:
5158
South Asian (SAS)
AF:
0.226
AC:
1091
AN:
4830
European-Finnish (FIN)
AF:
0.385
AC:
4073
AN:
10570
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.216
AC:
14692
AN:
67970
Other (OTH)
AF:
0.191
AC:
402
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1154
2309
3463
4618
5772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
314
628
942
1256
1570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.190
Hom.:
2900
Bravo
AF:
0.166
Asia WGS
AF:
0.366
AC:
1273
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 05, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 21, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.38
DANN
Benign
0.59
PhyloP100
-4.4
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6811856; hg19: chr4-3494826; COSMIC: COSV60772560; COSMIC: COSV60772560; API